HR
MDT icon

Hayden Royal’s Medtronic MDT Stock Holding History

Hayden Royal’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,646
Closed -$205K – 153
2021
Q2 		$205K Sell
1,646
-502
-23% -$63K 0.11% 187
2021
Q1 		$255K Sell
2,148
-11
-0.5% -$1.29K 0.15% 154
2020
Q4 		$254K Sell
2,159
-18
-0.8% -$1.98K 0.14% 172
2020
Q3 		$227K Sell
2,177
-26
-1% -$2.61K 0.12% 173
2020
Q2 		$203K Sell
2,203
-542
-20% -$52K 0.11% 148
2020
Q1 		$249K Buy
2,745
+578
+27% +$61.5K 0.15% 176
2019
Q4 		$244K Sell
2,167
-938
-30% -$103K 0.12% 177
2019
Q3 		$337K Buy
3,105
+344
+12% +$35.9K 0.3% 115
2019
Q2 		$275K Buy
+2,761
New +$252K 0.29% 107
2019
Q1 		– Sell
-8,835
Closed -$804K – 173
2018
Q4 		$804K Buy
+8,835
New +$826K 0.41% 58

Other funds holding MDT

WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hayden Royal's MDT Position: Q3 2021 in Review

Hayden Royal sold out of Medtronic (MDT) in Q3 2021, closing a stake of 1,646 shares — an estimated $205K sold.

Hayden Royal first reported a position in MDT in Q4 2018 and held it in 10 quarters. The position peaked at $804K in Q4 2018. 2,023 funds tracked by Wall St. Rank hold MDT as of Q3 2021.

  • Hayden Royal reported no remaining Medtronic position as of Q3 2021 after selling out during the quarter.
  • Hayden Royal sold 1,646 Medtronic shares in Q3 2021, an estimated $205K.
  • Hayden Royal first reported a position in Medtronic in Q4 2018 and held it in 10 quarters.
  • Hayden Royal's Medtronic position peaked at $804K in Q4 2018.
  • 2,023 funds tracked by Wall St. Rank held Medtronic as of Q3 2021.

Based on Hayden Royal's 13F filing for Q3 2021, filed 15 Nov 2021.